Cardiac magnetic resonance imaging R2* assessments and analysis of historical parameters in patients with transfusion-dependent thalassemia

Haematologica

Volumn 92, Issue 1, 2007, Pages 131-132

  Aessopos, Athanassios ^a,d   Fragodimitri, Christina ^b   Karabatsos, Fotios ^b   Hatziliami, Antonia ^b   Yousef, Jacqueline ^b   Giakoumis, Anastasios ^a   Dokou, Aikaterini ^b   Gotsis, Efstathios D ^c   Berdoukas, Vasilis ^b   Karagiorga, Markissia ^b  

^a UNIVERSITY OF ATHENS   (Greece)

^b AGHIA SOPHIA CHILDREN S HOSPITAL   (Greece)

^c Institute Euromedica Encephalos   (Greece)

^d UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Cardiac R2*; Iron overload; MRI; Thalassemia

Indexed keywords

DEFEROXAMINE; FERRITIN; IRON;

ARTICLE; BLOOD TRANSFUSION; CHELATION THERAPY; CHEMICAL PARAMETERS; HEART LEFT VENTRICLE EJECTION FRACTION; HEART VENTRICLE SEPTUM; HUMAN; IRON OVERLOAD; NUCLEAR MAGNETIC RESONANCE IMAGING; THALASSEMIA;

BLOOD TRANSFUSION; CHELATING AGENTS; HUMANS; IRON; IRON OVERLOAD; LIVER; MAGNETIC RESONANCE IMAGING; MYOCARDIUM; PREDICTIVE VALUE OF TESTS; SOFTWARE; THALASSEMIA; TIME FACTORS;

EID: 33846894766     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: 10.3324/haematol.10455     Document Type: Article

References (6)

1. St. Pierre T, Clark P, Chua-anusorn W, Fleming AJ, Jeffrey G, Olynyk J, et al. Noninvasive measurement and imaging or liver iron concentrations using proton magnetic resonance. Blood 2005;105:2:855-61.
2. Anderson L, Holden S, Davis B, et al. Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. Eur Heart J 2001;22:2171-9.
3. Westwood MA, Firmin DN, Matta G, Gallenello R, Gotsis S, Karagiorga M, et al. Intercentre reproducibility of cardiovascular magnetic resonance T2* measurements of myocardial iron in thalassemia. Int J Cardiac Imag 2005;21:531-8.
4. Pennell DJ, Berdoukas V, Karagiorga M, Ladis V, Piga A, Aessopos A, et al. Randomized controlled trial or deferiprone or deferoxamine in β-thalassemia major patients with asymptomatic myocardial siderosis. Blood 2006;107:3738-44.
5. Telfer PT, Prestcott E, Holden S, Walker M, Hoffbrand AV, Wonke B. Hepatic iron concentration combined with long-term monitoring of serum ferritin to predict complications of iron overload in thalassaemia major. Br J Haematol 2000;110:971-7
6. . Olivieri NF, Nathan DG, MacMillan JH, Wayne AS, Liu PP, McGee A, et al. Survival in medically treated patients with homozygous β-thalassemia. N Eng J Med 1994;331:574-8.